<p>2025 年 10 月 27 日- 上午 08:40</p>
<p>新加坡，2025 年 10 月 27 日（GLOBE NEWSWIRE）-- <strong>Cuprina Holdings (Cayman) Limited</strong>（<strong>纳斯达克：CUPR</strong>）（“<strong>Cuprina</strong>” 或 “<strong>公司</strong>”），是一家开发和营销慢性伤口、不孕症和美容药品领域产品的生物医学公司，今天表示已与新加坡生物废物解决方案私人有限公司（SBS）签署了一份谅解备忘录（MOU），以探索将 Cuprina 的医疗废物回收技术整合到 SBS 在新加坡现有的废物管理设施中。</p>
<p>此次合作旨在开发一个综合流程，进一步减少对焚烧和填埋的依赖，提高回收效率，开辟来自回收材料的新收入来源，并将公司及新加坡定位为可持续废物管理的领导者。</p>
<p>根据谅解备忘录，Cuprina 将提供技术专长、培训和支持，以进行这一探索，形式为在 SBS 设施内进行可行性研究和试点项目。在此期间，Cuprina 将利用其在东南亚的独家许可权，采用一种称为高温蒸汽处理的工艺（即高压灭菌），对塑料医疗废物进行灭菌、去污和回收，转化为高价值树脂。这项技术是在联合国工业发展组织（UNIDO）和全球环境基金（GEF）的监督下开发的，旨在共同资助全球环境目标。</p>
<p>根据谅解备忘录，SBS 将提供必要的运营数据、设施访问和监管支持，以促进公司联合废物回收流程与新加坡环境标准的整合，并确保符合新加坡国家环境局和卫生部等当局的要求。</p>
<p>两家公司将共同寻求为综合流程开发收入分享模型，并探索在东南亚推广该技术的机会；</p>
<p>“我们很高兴签署这份谅解备忘录，标志着 Cuprina 首次可能商业化我们最近获得许可的医疗废物回收技术，” Cuprina 首席执行官 David Quek Yong Qi 表示。“我们对这项技术感到乐观，该技术在 UNIDO 和 GEF 的合作下经过 20 年的开发和测试，将与 SBS 的废物管理流程完美整合。我们期待与 SBS 在我们的试点项目上合作，并在不久的将来达成最终协议。”</p>
<p>Quek 先生表示，他相信公司的综合回收技术能够获得所有必要的新加坡监管批准，并在 2026 年底前开始运营。</p>
<p>SBS 董事总经理 Selva Kumar 补充道：“我们很高兴与 Cuprina 合作，采用这种创新的废物管理方法。我们相信，将他们的技术整合到我们的流程中，将帮助我们满足不断变化的环境法规，并为新加坡及其他地区的循环经济做出贡献。”</p>
<p><strong>关于 Cuprina Holdings (Cayman) Limited</strong></p>
<p>我们是一家总部位于新加坡的生物医学和生物技术公司，致力于开发和商业化用于慢性伤口管理的创新产品，同时在健康和美容领域运营。我们在生物医学研究方面的专业知识使我们能够识别和利用来自自然来源的材料，开发符合国际标准的医疗设备形式的伤口护理产品。</p>
<p>欲了解更多信息，请访问</p>
<p><strong>关于新加坡生物废物解决方案私人有限公司</strong></p>
<p>新加坡生物废物解决方案私人有限公司是新加坡最先进的生物医学废物处置和管理提供商。该公司提供最先进的技术、高度训练的运营专家团队、先进的设施，以及对客户需求的坚定承诺。</p>
<p><strong>前瞻性声明</strong></p>
<p>本新闻稿中包含的某些关于未来期望、计划和前景的声明，以及关于非历史事实事项的其他声明，可能构成 1995 年《私人证券诉讼改革法》所定义的 “前瞻性声明”。这些声明包括但不限于与预期交易开始和结束日期相关的声明。词语 “预期”、“相信”、“继续”、“可能”、“估计”、“期望”、“打算”、“可能”、“计划”、“潜在”、“预测”、“项目”、“应该”、“目标”、“将”、“会” 等类似表达旨在识别前瞻性声明，尽管并非所有前瞻性声明都包含这些识别词。实际结果可能因各种重要因素而与这些前瞻性声明所指示的结果有重大差异，包括：与市场条件相关的不确定性以及公共发行是否按预期条款完成或根本不完成的其他因素，以及在向 SEC 提交的初步招股说明书的 “风险因素” 部分中讨论的其他因素。因此，投资者被警告不要对本新闻稿中的任何前瞻性声明过度依赖。任何包含在本新闻稿中的前瞻性声明仅在本日期有效，Cuprina Holdings (Cayman) Limited 特别声明不承担更新任何前瞻性声明的义务，无论是由于新信息、未来事件还是其他原因，法律要求的情况除外。</p>
<p><strong>Cuprina Holdings (Cayman) Limited 投资者联系：</strong></p>
<p>投资者关系</p>
<p>c/o Blk 1090 Lower Delta Road #06-08</p>
<p>新加坡 169201</p>
<p>+65 8512 7275</p>
<p>电子邮件：ir@cuprina.com.sg</p>
<p><strong>投资者关系咨询：</strong></p>
<p>Skyline Corporate Communications Group, LLC</p>
<p>Scott Powell, 总裁</p>
<p>1177 Avenue of the Americas, 5th Floor</p>
<p>纽约，纽约 10036</p>
<p>办公室：（646）893-5835</p>
<p>电子邮件：info@skylineccg.com</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.globenewswire.com/newsroom/ti/query-bmY9T1RVMk1qVTBNaU0zTWpJMk1UZ3dJelV3TURFeU9EWTNNZz09?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.globenewswire.com/newsroom/ti/query-bmY9T1RVMk1qVTBNaU0zTWpJMk1UZ3dJelV3TURFeU9EWTNNZz09"/></p>
<p><img src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/media/Njk2Y2YzOTEtZDM4Ni00OGI3LTgxNDYtYTc4MjFjMjAyOTdiLTUwMDEyODY3Mi0yMDI1LTEwLTI3LWVu/tiny/Cuprina-Holdings-Cayman-LTD.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/media/Njk2Y2YzOTEtZDM4Ni00OGI3LTgxNDYtYTc4MjFjMjAyOTdiLTUwMDEyODY3Mi0yMDI1LTEwLTI3LWVu/tiny/Cuprina-Holdings-Cayman-LTD.png"/></p>

CUPR

<p>Cuprina Holdings 已与新加坡生物废物解决方案公司签署了一份谅解备忘录（MOU），将其医疗废物回收技术整合到 SBS 的废物管理设施中。此次合作旨在减少对焚烧的依赖，提高回收效率，并创造新的收入来源。Cuprina 将提供技术专长并进行可行性研究，利用其对医疗废物回收高温蒸汽工艺的独占权利。两家公司旨在遵守新加坡的环境标准，并探索在东南亚的扩展机会</p>

<p>10/27/2025 - 08:40 AM</p>
<div class="lb-trans"><p>2025 年 10 月 27 日- 上午 08:40</p>
</div><p>SINGAPORE, Oct. 27, 2025 (GLOBE NEWSWIRE) -- <strong>Cuprina Holdings (Cayman) Limited</strong> ( <strong>Nasdaq: CUPR</strong>) (“ <strong>Cuprina</strong>” or “ <strong>the Company</strong>”), a biomedical company developing and marketing products for the chronic wounds, infertility, and cosmeceuticals sectors, today said it has signed a Memorandum of Understanding (MOU) with Singapore Biowaste Solutions Pte Ltd (SBS), a treater and disposer of bio-medical waste, to explore the integration of Cuprina’s medical waste recycling technology into SBS's existing waste management facility in Singapore.</p>
<div class="lb-trans"><p>新加坡，2025 年 10 月 27 日（GLOBE NEWSWIRE）-- <strong>Cuprina Holdings (Cayman) Limited</strong>（<strong>纳斯达克：CUPR</strong>）（“<strong>Cuprina</strong>” 或 “<strong>公司</strong>”），是一家开发和营销慢性伤口、不孕症和美容药品领域产品的生物医学公司，今天表示已与新加坡生物废物解决方案私人有限公司（SBS）签署了一份谅解备忘录（MOU），以探索将 Cuprina 的医疗废物回收技术整合到 SBS 在新加坡现有的废物管理设施中。</p>
</div><p>The collaboration aims to develop an integrated process that will further reduce reliance on incineration and landfilling, enhance recycling efficiency, unlock new revenue streams from recycled materials, and position the companies and Singapore as leaders in sustainable waste management.</p>
<div class="lb-trans"><p>此次合作旨在开发一个综合流程，进一步减少对焚烧和填埋的依赖，提高回收效率，开辟来自回收材料的新收入来源，并将公司及新加坡定位为可持续废物管理的领导者。</p>
</div><p>Pursuant to the MOU, Cuprina will provide technical expertise, training, and support for this exploration, which will take the form of a feasibility study and pilot program at SBS’s facility. During this period, Cuprina will leverage its exclusive Southeast Asia licensing rights to a high-temperature steam process known as autoclaving to sterilize, decontaminate, and recycle plastic-based medical waste into high-value resins. This technology is the first of its kind developed under the oversight of the United Nations Industrial Development Organization (UNIDO) and Global Environment Facility (GEF), which work together to fund global environmental goals.</p>
<div class="lb-trans"><p>根据谅解备忘录，Cuprina 将提供技术专长、培训和支持，以进行这一探索，形式为在 SBS 设施内进行可行性研究和试点项目。在此期间，Cuprina 将利用其在东南亚的独家许可权，采用一种称为高温蒸汽处理的工艺（即高压灭菌），对塑料医疗废物进行灭菌、去污和回收，转化为高价值树脂。这项技术是在联合国工业发展组织（UNIDO）和全球环境基金（GEF）的监督下开发的，旨在共同资助全球环境目标。</p>
</div><p>As per the MOU, SBS will contribute the operational data, facility access, and regulatory support necessary to facilitate integration of the companies’ combined waste recycling process with Singapore’s environmental standards, and to secure compliance with Singapore authorities such as the National Environment Agency and Ministry of Health.</p>
<div class="lb-trans"><p>根据谅解备忘录，SBS 将提供必要的运营数据、设施访问和监管支持，以促进公司联合废物回收流程与新加坡环境标准的整合，并确保符合新加坡国家环境局和卫生部等当局的要求。</p>
</div><p>Together, the companies will seek to develop revenue-sharing models for the integrated process and explore expansion opportunities for the technology across Southeast Asia;</p>
<div class="lb-trans"><p>两家公司将共同寻求为综合流程开发收入分享模型，并探索在东南亚推广该技术的机会；</p>
</div><p>“We are excited to sign this MOU, representing Cuprina’s first potential commercialization of our recently licensed medical waste recycling technology,” said Cuprina CEO, David Quek Yong Qi. “We are optimistic that this technology, developed and tested over 20 years with UNIDO and GEF, will integrate superbly with SBS’ waste management processes. We look forward to working with SBS on our pilot program and arriving at a definitive agreement in the near future.”</p>
<div class="lb-trans"><p>“我们很高兴签署这份谅解备忘录，标志着 Cuprina 首次可能商业化我们最近获得许可的医疗废物回收技术，” Cuprina 首席执行官 David Quek Yong Qi 表示。“我们对这项技术感到乐观，该技术在 UNIDO 和 GEF 的合作下经过 20 年的开发和测试，将与 SBS 的废物管理流程完美整合。我们期待与 SBS 在我们的试点项目上合作，并在不久的将来达成最终协议。”</p>
</div><p>Mr. Quek said he believed the companies’ integrated recycling technology could obtain all necessary Singapore regulatory approvals and commence operations by the end of 2026.</p>
<div class="lb-trans"><p>Quek 先生表示，他相信公司的综合回收技术能够获得所有必要的新加坡监管批准，并在 2026 年底前开始运营。</p>
</div><p>SBS Managing Director, Selva Kumar added, “We are thrilled to collaborate with Cuprina on this innovative approach to waste management. Integrating their technology into our processes will, we believe, help us meet evolving environmental regulations and contribute to a circular economy in Singapore and beyond.”</p>
<div class="lb-trans"><p>SBS 董事总经理 Selva Kumar 补充道：“我们很高兴与 Cuprina 合作，采用这种创新的废物管理方法。我们相信，将他们的技术整合到我们的流程中，将帮助我们满足不断变化的环境法规，并为新加坡及其他地区的循环经济做出贡献。”</p>
</div><p><strong>About Cuprina Holdings (Cayman) Limited</strong></p>
<div class="lb-trans"><p><strong>关于 Cuprina Holdings (Cayman) Limited</strong></p>
</div><p>We are a Singapore-based biomedical and biotechnology company that is dedicated to the development and commercialization of innovative products for the management of chronic wounds, as well as operating in the health and beauty sectors. Our expertise in biomedical research allows us to identify and utilize materials derived from natural sources to develop wound care products in the form of medical devices which meet international standards.</p>
<div class="lb-trans"><p>我们是一家总部位于新加坡的生物医学和生物技术公司，致力于开发和商业化用于慢性伤口管理的创新产品，同时在健康和美容领域运营。我们在生物医学研究方面的专业知识使我们能够识别和利用来自自然来源的材料，开发符合国际标准的医疗设备形式的伤口护理产品。</p>
</div><p>For more information, please visit</p>
<div class="lb-trans"><p>欲了解更多信息，请访问</p>
</div><p><strong>About</strong> <strong>Singapore Biowaste Solutions Pte Ltd</strong></p>
<div class="lb-trans"><p><strong>关于新加坡生物废物解决方案私人有限公司</strong></p>
</div><p>Singapore Biowaste Solutions Pte Ltd is Singapore’s most advanced provider for bio-medical waste disposal and management. The company offers state-of-the art technologies, a highly trained team of operational experts, advanced facilities, and unwavering commitment to the needs of its clients.</p>
<div class="lb-trans"><p>新加坡生物废物解决方案私人有限公司是新加坡最先进的生物医学废物处置和管理提供商。该公司提供最先进的技术、高度训练的运营专家团队、先进的设施，以及对客户需求的坚定承诺。</p>
</div><p><strong>FORWARD-LOOKING STATEMENTS</strong></p>
<div class="lb-trans"><p><strong>前瞻性声明</strong></p>
</div><p>Certain statements contained in this press release about future expectations, plans and prospects, as well as any other statements regarding matters that are not historical facts, may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements relating to the expected trading commencement and closing dates. The words “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “should,” “target,” “will,” “would” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including: the uncertainties related to market conditions and the completion of the public offering on the anticipated terms or at all, and other factors discussed in the “Risk Factors” section of the preliminary prospectus filed with the SEC. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Any forward-looking statements contained in this press release speak only as of the date hereof, and Cuprina Holdings (Cayman) Limited specifically disclaims any obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by law.</p>
<div class="lb-trans"><p>本新闻稿中包含的某些关于未来期望、计划和前景的声明，以及关于非历史事实事项的其他声明，可能构成 1995 年《私人证券诉讼改革法》所定义的 “前瞻性声明”。这些声明包括但不限于与预期交易开始和结束日期相关的声明。词语 “预期”、“相信”、“继续”、“可能”、“估计”、“期望”、“打算”、“可能”、“计划”、“潜在”、“预测”、“项目”、“应该”、“目标”、“将”、“会” 等类似表达旨在识别前瞻性声明，尽管并非所有前瞻性声明都包含这些识别词。实际结果可能因各种重要因素而与这些前瞻性声明所指示的结果有重大差异，包括：与市场条件相关的不确定性以及公共发行是否按预期条款完成或根本不完成的其他因素，以及在向 SEC 提交的初步招股说明书的 “风险因素” 部分中讨论的其他因素。因此，投资者被警告不要对本新闻稿中的任何前瞻性声明过度依赖。任何包含在本新闻稿中的前瞻性声明仅在本日期有效，Cuprina Holdings (Cayman) Limited 特别声明不承担更新任何前瞻性声明的义务，无论是由于新信息、未来事件还是其他原因，法律要求的情况除外。</p>
</div><p><strong>Cuprina Holdings (Cayman) Limited Investor Contact:</strong></p>
<div class="lb-trans"><p><strong>Cuprina Holdings (Cayman) Limited 投资者联系：</strong></p>
</div><p>Investor Relations</p>
<div class="lb-trans"><p>投资者关系</p>
</div><p>c/o Blk 1090 Lower Delta Road #06-08</p>
<div class="lb-trans"><p>c/o Blk 1090 Lower Delta Road #06-08</p>
</div><p>Singapore 169201</p>
<div class="lb-trans"><p>新加坡 169201</p>
</div><p>+65 8512 7275</p>
<div class="lb-trans"><p>+65 8512 7275</p>
</div><p>Email: ir@cuprina.com.sg</p>
<div class="lb-trans"><p>电子邮件：ir@cuprina.com.sg</p>
</div><p><strong>Investor Relations Inquiries:</strong></p>
<div class="lb-trans"><p><strong>投资者关系咨询：</strong></p>
</div><p>Skyline Corporate Communications Group, LLC</p>
<div class="lb-trans"><p>Skyline Corporate Communications Group, LLC</p>
</div><p>Scott Powell, President</p>
<div class="lb-trans"><p>Scott Powell, 总裁</p>
</div><p>1177 Avenue of the Americas, 5th Floor</p>
<div class="lb-trans"><p>1177 Avenue of the Americas, 5th Floor</p>
</div><p>New York, New York 10036</p>
<div class="lb-trans"><p>纽约，纽约 10036</p>
</div><p>Office: (646) 893-5835</p>
<div class="lb-trans"><p>办公室：（646）893-5835</p>
</div><p>Email: info@skylineccg.com</p>
<div class="lb-trans"><p>电子邮件：info@skylineccg.com</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.globenewswire.com/newsroom/ti/query-bmY9T1RVMk1qVTBNaU0zTWpJMk1UZ3dJelV3TURFeU9EWTNNZz09" alt="" original-src="https://www.globenewswire.com/newsroom/ti?nf=OTU2MjU0MiM3MjI2MTgwIzUwMDEyODY3Mg=="/></p>
<p><img src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/media/Njk2Y2YzOTEtZDM4Ni00OGI3LTgxNDYtYTc4MjFjMjAyOTdiLTUwMDEyODY3Mi0yMDI1LTEwLTI3LWVu/tiny/Cuprina-Holdings-Cayman-LTD.png" alt="" original-src="https://ml.globenewswire.com/media/Njk2Y2YzOTEtZDM4Ni00OGI3LTgxNDYtYTc4MjFjMjAyOTdiLTUwMDEyODY3Mi0yMDI1LTEwLTI3LWVu/tiny/Cuprina-Holdings-Cayman-LTD.png"/></p>

Cuprina 与新加坡生物废物解决方案公司签署谅解备忘录，整合医疗废物管理技术 | CUPR 股票新闻